Access Resources
1221 - 1230 of 7574 Results
Title
Year
- Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis2022RESTRICTEDTitle: Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 119End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.004Citation Count: 11
-
RESTRICTEDTitle: Cellular senescence: a key therapeutic target in aging and diseasesJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 132Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci158450Best OA location URL: http://www.jci.org/articles/view/158450/files/pdfCitation Count: 110
- Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants2022RESTRICTEDTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 6
- DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 template2022RESTRICTEDTitle: DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 templateJournal Name: NeuroImagePublisher: Elsevier BVVol: 257Issue #:Start Page: 119266End Page: 119266Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119266Best OA location URL: https://doi.org/10.1016/j.neuroimage.2022.119266Citation Count: 8
-
RESTRICTEDTitle: Diagnosis and treatment of orthostatic hypotensionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 735End Page: 746Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00169-7Best OA location URL: https://pure.rug.nl/ws/files/234637992/1_s2.0_S1474442222001697_main.pdfCitation Count: 46
- Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat2022RESTRICTEDTitle: Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned ratJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 929Issue #:Start Page: 175090End Page: 175090Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175090Best OA location URL: https://doi.org/10.1016/j.ejphar.2022.175090Citation Count: 6
-
RESTRICTEDTitle: Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 170Issue #:Start Page: 105744End Page: 105744Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105744Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105744Citation Count: 15
-
RESTRICTEDTitle: Genome Sequencing in the Parkinson Disease ClinicJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200002Best OA location URL: https://ng.neurology.org/content/nng/8/4/e200002.full.pdfCitation Count: 8
- Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic2022RESTRICTEDTitle: Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinicJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0055Citation Count: 6
- Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age2022RESTRICTEDTitle: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageJournal Name: eBioMedicinePublisher: Elsevier BVVol: 82Issue #:Start Page: 104179End Page: 104179Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104179Best OA location URL: http://www.thelancet.com/article/S2352396422003607/pdfCitation Count: 19